Table 1.
Histologic type | Number |
---|---|
DCIS n = 23 (27.1%) | Histological grade DCIS |
Grade 1 0 | |
Grade 2 12 | |
Grade 3 11 | |
Invasive breast cancer n = 62 (72.9%) (Invasive breast cancer with DCIS component n = 25) |
Histology-invasive breast cancer Invasive breast cancer no special type 54 Invasive lobular carcinoma 6 Other 2 |
Histological grade invasive breast cancer Bloom and Richardson Grade 1 7 Bloom and Richardson Grade 2 30 Bloom and Richardson Grade 3 25 | |
Size invasive breast cancer ≤ 10 mm 35 (56.5%) > 10 ≤ 20 mm 25 (40.3%) > 20 mm 2 (3.2%) | |
Receptor status invasive breast cancer n = 59* ER+ and/or PR+, HER2− 42 (71.2%) ER+, PR+, HER2+ 3 (5.1%) ER−, PR−, HER2+ 3 (5.1%) ER+, PR_, HER2+ 1 (1.7%) Triple− 10 (16.9%) | |
Nodal status n = 61*** |
N+ 19.7%** (12/61) N− 80.3% (49/61) |
DCIS ductal carcinoma in situ, HER2 human epidermal growth factor receptor 2
*Her2 status not available in 3 patients
**Including 4 cases with micrometastases
*** Nodal status unknown in one patient with invasive breast cancer